Fundraising Fox
🦊/Companies
Sign in

Actio Biosciences

2 known investors

Find your way into Actio Biosciences

Actio is a precision medicine company developing therapeutics by leveraging genetic insights to treat rare diseases and common conditions at their molecular root. The company focuses on identifying genes with dysregulated activity and designing therapies to restore normal gene function.

AI & Machine LearningBiotech

Investors · 2

Droia VenturesLeuven · $540K
Deerfield Management CompanyreportedNew York

Funding

SEC filings, press & company announcements

$66M disclosed across 1 of 2 rounds · 2023–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Actio Biosciences Raises $66M in Series B to Advance Genetics-Based Therapies - Pharma Journalistpharmajournalist.com · Jun 2025Actio gains $66m to advance small molecule therapeutics pipelinefinance.yahoo.com · Jun 2025Actio Biosciences Raises $66M in Series B Financingfinsmes.com · Jun 2025Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven Pipeline of Small Molecule Therapeutics for Rare and Common Diseases • Actio Biosciencesactiobiosciences.com · Jun 2025Actio Biosciences Raises $55 Million to Advance Precision Medicine Approach for Rare and Common Diseases - Global Genesglobalgenes.org · Sep 2023

Frequently asked questions

What does Actio Biosciences do?
Actio is a precision medicine company developing therapeutics by leveraging genetic insights to treat rare diseases and common conditions at their molecular root. The company focuses on identifying genes with dysregulated activity and designing therapies to restore normal gene function.
Who are Actio Biosciences's investors?
Actio Biosciences's investors include Droia Ventures, Deerfield Management Company.
How much funding has Actio Biosciences raised?
Actio Biosciences has disclosed $66M raised across 1 of its 2 known rounds.